SEC Form 4
Neuropace, Inc. (NPCE) insider trading
In the 12 months to Oct 26, 2026, one NPCE insider reported open-market sales of $399.3K across 1 filing; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $399.3K
- 1 filing · 1 insider
- Open-market purchases
- $0
- 0 filings
Who traded NPCE, and when
- Sale
NPCE daily close from Oct 27, 2025 to Oct 26, 2026, between $9.40 and $19.29, last $12.98. 1 sale and 0 purchase filings by 1 insider, marked at their filing dates. Martha Morrell, CHIEF MEDICAL OFFICER: sold $399.3K across 1 filing, first filed Mar 4, 2026, last Mar 4, 2026.
Largest mark · tap a row for others
Martha Morrell · CHIEF MEDICAL OFFICER
Sale $399,250
25,000 shares at $15.97 avg
Filed Mar 4, 2026 · traded Dec 15
Close on filing date $13.95
Martha Morrell · CHIEF MEDICAL OFFICER
CHIEF MEDICAL OFFICER
$399.3K soldOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Martha Morrell | CHIEF MEDICAL OFFICER | $399.3K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Martha Morrell CHIEF MEDICAL OFFICER | Sale | 25,000 | $15.97 | $399.3K | 49,964 |
GET /stocks/filings/vX/form-4?tickers=NPCE&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"NPCE"
],
"issuer_cik": "0001528287",
"owner_cik": "0001855616",
"accession_number": "0001855616-26-000007",
"form_type": "4",
"filing_date": "2026-03-04",
"period_of_report": "2025-12-15",
"issuer_name": "NeuroPace Inc",
"issuer_trading_symbol": "NPCE",
"owner_name": "Morrell Martha",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CHIEF MEDICAL OFFICER",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2025-12-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 25000,
"transaction_price_per_share": 15.97,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 49964,
"transaction_value": 399250,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."
},
{
"id": "F2",
"description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to\nprovide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."
}
]
}
]
}
// trimmed to 1 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 39 records
- Tax withholding19 records
- Grants and awards20 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Neuropace, Inc.'s CEO sold stock?
No. Joel Becker (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is NPCE’s insider data?
These are NPCE Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track NPCE insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for NPCE every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.